ArticleNeurobiology of disease2019
The UPR-PERK pathway is not a promising therapeutic target for mutant SOD1-induced ALS.
Yulia Dzhashiashvili et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
this papercites it